Video Experimental Relacionado
Updated: May 11, 2026
10:24
Xenopus laevis as a Model to Identify Translation Impairment
Published on: September 27, 2015
Inhibición de moléculas pequeñas de la interacción entre los factores de iniciación de la traducción eIF4E y eIF4G
Nathan J Moerke1, Huseyin Aktas, Han Chen
1Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA.
Cell
|January 27, 2007
Resumen
Los investigadores desarrollaron un compuesto, 4EGI-1, que inhibe el complejo eIF4E/eIF4G, un regulador clave de la expresión génica. Este compuesto se muestra prometedor como una nueva terapia contra el cáncer al apuntar a la iniciación de la traducción.
Área de la Ciencia:
- Biología Molecular Biología Molecular
- Investigación del cáncer Investigación del cáncer.
- Descubrimiento de Drogas Descubrimiento de Drogas
Sus antecedentes:
- El complejo del factor de iniciación de la traducción eucariota 4E (eIF4E) y del factor de iniciación de la traducción eucariota 4G (eIF4G) es crucial para la regulación de la expresión génica.
- Las proteínas de unión 4E (4E-BPs) inhiben este complejo y poseen actividad supresora de tumores.
Objetivo del estudio:
- Desarrollar un ensayo de cribado de alto rendimiento para identificar moléculas pequeñas que inhiben la interacción eIF4E/eIF4G.
- Para imitar farmacológicamente la función de 4E-BPs.
Principales métodos:
- Desarrollo de ensayos de cribado de alto rendimiento.
- Ensayos in vitro y celulares para evaluar la actividad del compuesto.
- Análisis de las interacciones proteína-proteína e inhibición de la traducción.
Principales resultados:
- 4EGI-1 identificado como un potente inhibidor de la interacción eIF4E/eIF4G.
- 4EGI-1 inhibe la traducción dependiente de la capa y mejora la asociación 4E-BP1.
- Demostró la eficacia de 4EGI-1 contra múltiples líneas celulares de cáncer, en particular las células transformadas.
Conclusiones:
- 4EGI-1 proporciona una nueva herramienta para el estudio del control traslacional.
- Los hallazgos establecen una nueva estrategia terapéutica potencial para el cáncer al dirigirse a la iniciación de la traducción.
Videos de Conceptos Relacionados
02:07Improving Translational Accuracy
Base complementarity between the three base pairs of mRNA codon and the tRNA anticodon is not a failsafe mechanism. Inaccuracies can range from a single mismatch to no correct base pairing at all. The free energy difference between the correct and nearly correct base pairs can be as small as 3 kcal/ mol. With complementarity being the only proofreading step, the estimated error frequency would be one wrong amino acid in every 100 amino acids incorporated. However, error frequencies observed in...
02:33Initiation of Translation
Initiating translation is complex because it involves multiple molecules. Initiator tRNA, ribosomal subunits, and eukaryotic initiation factors (eIFs) are all required to assemble on the initiation codon of mRNA. This process consists of several steps that are mediated by different eIFs.
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
01:52Eukaryotic Transcription Inhibitors
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
02:33Initiation of Translation
Initiating translation is complex because it involves multiple molecules. Initiator tRNA, ribosomal subunits, and eukaryotic initiation factors (eIFs) are all required to assemble on the initiation codon of mRNA. This process consists of several steps that are mediated by different eIFs.
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
01:25Inhibitors of Bacterial Protein Synthesis
Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...